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Abstract: In recent years, glycopolymers have particularly revolutionized the world of 
macromolecular chemistry and materials in general. Nevertheless, it has been in this 
century when scientists realize that these materials present great versatility in biosensing, 
biorecognition, and biomedicine among other areas. This article highlights most relevant 
glycopolymeric materials, considering that they are only a small example of the research 
done in this emerging field. The examples described here are selected on the base of novelty, 
innovation and implementation of glycopolymeric materials. In addition, the future 
perspectives of this topic will be commented on. 
Keywords: glycopolymers; biorecognition; anti-adhesion therapy; bioactive delivery; 
vaccines; sensors; imaging; diagnostics 
 
1. Introduction 
It is well known that carbohydrates located in the cell membrane as glycoproteins, glycolipids or 
glycans play a crucial role in many physiological as well as pathological events, including cellular 
proliferation and cancer metastasis, intercellular communication, recognition processes, adhesion, etc. 
This is mainly as a result of specific interactions of the carbohydrates with protein receptors such as 
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enzymes or lectins that triggering the above mentioned biological functions. This molecular recognition 
ability is greatly enhanced by multivalency or the so-called glycocluster effect [1,2], commonly found in 
natural glycoproteins or glycolipids clusters that strongly recognize sugar-binding proteins.  
Numerous investigations have been focused on the preparation of synthetic glycopolymers with 
pendant sugar moieties along the polymer backbone or at the end of the chain, which are able to 
interact with lectins through multivalent interactions, mimicking natural biomolecules. Especially 
interesting are the controlled polymerization techniques and efficient chemical reactions such as click 
chemistry to tune the architecture of the glycopolymers and optimize the recognition process [3–5]. 
The design of the glycopolymer is essential, because the strength of the binding strongly depends on 
the type of sugars, anomeric status, and linkage position and the linker that connects the carbohydrate 
to the polymer backbone, and also on the density of sugars, degree of polymerization and branching [6]. 
For example, by increasing the polymer length, then the valence, polymers can access to multiple 
binding sites in proteins, thereby increasing their affinity. Nevertheless, when all accessible binding 
sites are occupied, further increase in polymer length will not yield enhancements in their interaction. 
Moreover, more flexible backbones and linkers allow polymer to adopt a conformation/orientation that 
leads to effective interactions. It is important to mention that the interaction between glycopolymer and 
lectin is exclusive for each binomial team; that is, the best polymer structure for a particular lectin is 
not necessarily the optimum structure for other lectins, even those with the same carbohydrate specificity. 
Synthetic polymeric techniques such as reversible addition-fragmentation chain transfer 
polymerization (RAFT) [7] and atom transfer radical polymerization (ATRP) [8] allow the 
development of well-defined glycopolymers of a variety of composition and topologies, including 
homopolymers, statistical and block copolymers.  
In the last years, efforts were mainly dedicated to the synthesis of new glycopolymer structures and 
their use as biomimetic model to fundamentally investigate the specific carbohydrate-protein 
interactions. Nowadays, besides the synthetic development, glycopolymeric nanostructures, both 
polymer glyconanoparticles and hybrid nanoparticles are receiving more and more attention. 
Nanoparticles due to their size and high surface area have shown great potential in different fields, 
especially in biomedicine. Recently, research has demonstrated that the size and shape of the 
nanoparticles significantly influence their interactions with cells. A variety of approaches, such as 
grafting from or grafting on, have been used to prepare glyconanoparticles with different compositions, 
sizes and shapes to study and understand the interactions between particles and proteins and optimize 
their applicability [9].  
Based on the extensive investigations of the biological activity of the glycopolymers and how their 
structure affects the binding with lectins the focus of research has moved more to the pure applications 
of glycopolymers, which also contribute to amplify the knowledge in the recognition process. Lately, 
advancements in the applications of glycopolymers have shown an explosion, with the consolidation 
and advance of several uses, such as target delivery systems and also emerging new applications. This 
article will examine the most common and recent applications of glycopolymers particularly focused 
in biomedical and biological uses.  
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2. Biomimetic Model to Investigate Carbohydrate-Protein Interactions 
As mentioned above, glycopolymers can strongly interact with specific proteins, lectins, by the 
multivalent glycocluster effect. There are many fundamental examples that investigate glycopolymer-lectin 
recognition [10–23], especially with Concanavalin A, Con A, and Ricinus Communis Agglutinin 120, 
RCA120, mainly by UV-Vis or fluorescence spectroscopies; in the latter when either the lectin or the 
glycopolymer are fluorescence-labeled. It is well-known that Con A, which is a tetramer with four 
carbohydrate binding sites, specifically binds to glycopolymers containing mannosyl and glucosyl 
residues while RCA120 lectin interacts to those containing galactosyl residues. These residues have to 
be present in a specific form, otherwise there will be no interactions. This is the case of gluconolactone 
derivatives, where the glucose moieties are in an open-form and the interactions are not observed 
either with RCA120 or with Con A [24,25]. 
Moreover, the binding abilities of glycopolymers have been also measured by microarray and surface 
plasmon resonance (SPR) techniques [26–31]. Microarray technique of biomolecules, also called 
biochip, is a collection of microscopic spots of these molecules attached to a solid surface [32,33]. 
Meanwhile, surface plasmon resonance sensing is also a powerful and quantitative probe of the 
interactions of a variety of biopolymers with various ligands. It provides a means not only for 
identifying these interactions and quantifying their equilibrium constants, kinetic constants and 
underlying energetics, but also for employing them in very sensitive biochemical assays [34,35]. 
In this context, the glycopolymers can be efficiently attached to surfaces, where they approximate 
physiological cell–cell and cell–extracellular matrix interactions and retain the ability to engage 
proteins. This is the case of chondroitin sulfate glycomimetic polymers that present sulfated disaccharide 
units, which mimic the multivalent architecture of native glycosaminoglycans chains [27]. 
Glycopolymers were attached to microarray surfaces with a high-precision contact-printing robot 
delivering nanoliter volumes of the biotin-labeled glycopolymers to streptavidin-coated slides, yielding 
spots of approximately 200 mm in diameter (see Figure 1).  
 
Figure 1. Schematic representation of glycopolymers anchored on chips and their interaction. 
Bertozzi group has used the microcontact printing (mCP) technique to covalently array the 
glycopolymers on azide-functionalized biochips in well-defined patterns using a poly(dimethylsiloxane) 
stamp with approximately 2 mm circular structures [31]. They tested the binding effectiveness of  
Helix Pomatia Agglutinin (HPA) lectin, proving the specific interaction.  
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Narain group has studied the recognition ability of glyconanoparticles with immobilize lectins, i.e., 
N-acetyl β-D-glucosaminoside decorated gold nanoparticles, which specifically interact with wheat 
germ agglutinin (WGA) lectin, whereas α-D-mannoside derivatives specifically interact with Con A 
lectin. The glycopolymer structure gives the capability of lectin interaction, but can also infer other 
properties. This is the case of glycopolymers obtained by RAFT process, where the polymer is 
conjugated with tripeptide reduced glutathione (GSH) by thiol-disulfide exchange reaction [36].  
The resulting disulfide-linked GSH bioconjugate polymer (Figure 2) possesses antioxidant character, 
with prolonged radical scavenging activity. This is because of GSH, which can protect cells from 
oxidative stress through scavenging singlet oxygen, hydroxyl radicals, and superoxide radicals. 
Moreover, the specific recognition with Con A lectin is enhanced about three times when it is 
conjugated with a GSH, other than on its own. 
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Figure 2. Tripeptide reduced glutathione-bioconjugate glycopolymer structure. 
Stimuli-responsive structures enlarge the properties of glycopolymers and make the binding 
properties more versatile. For example, thermoreversible glycopolymers used to control lectin interaction 
or bacterial aggregation [37,38], where the binding between glycopolymer and lectin or bacteria is 
regulated by the polymer thermoreversibility. In the first case, the random glycopolymer based on  
N-isopropyl acrylamide (NIPAAm) and N-acryloyl glucosamine (AGA) is grafted from the 
honeycomb surface. Below the lower critical solution temperature (LCST) of the surface, the 
conjugation is switched off, while above the LCST the surface grafted glucose moieties bind strongly 
to Con A (Figure 3). Contrary effect is observed in the second example in which the block 
glycopolymer based also on NIPAAm is in solution. In this situation, when temperature is below its 
LCST, the chains are extended and display glucose moieties in solutions, then it is able to bind to the 
cell of Escherichia coli bacteria, whereas above LCST, the glycopolymer is presented in a globular 
state, which hides the carbohydrate moieties (Figure 4). 
 
Figure 3. Representation of interaction between random thermoreversible glycopolymers 
attached to surface and lectin. 
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Figure 4. Representation of interaction between block thermoreversible glycopolymers 
and bacteria in water solution. 
3. Anti-Adhesion Therapy 
Currently, one of the most attracting and emerging applications of glycopolymers is anti-adhesion 
therapy in which glycopolymers behave as antagonists to interfere with the binding of lectins from a 
pathogen to the host organism and, therefore, prevent infection from occurring. Glycopolymers have 
been designed to act against infections by different AB5 toxins, including the cholera toxin (CT),  
Shiga toxins, and the heat-labile enterotoxin (LT). Different degrees of carbohydrate incorporation 
have been obtained by post-modification of poly(L-glutamic acid) (PGA) backbone with  
N-(ԑ-aminocaproyl)-β-D-galactosylamine over the β-D-galactosylamine. The results indicate that 
higher accessibility of galactose in N-(ԑ-aminocaproyl)-β-D-galactosylamine improves the inhibition 
of binding [39,40].  
Moreover, glycopolymers bearing globotriose or lactose and acrylamide have been used to evaluate 
the inhibitory effects on cytotoxicity of Shiga toxins (Stxs; Stx1 and Stx2). The results showed that 
glycopolymers having globotriose units exhibited inhibitory effect on cytotoxicity of Stx1, while 
glycopolymers having small amount of acrylamide exhibited inhibitory effect on cytotoxicity of Stx2. 
Also, the glycopolymer, having lactose, was able to bind Stx1, showing inhibitory effect on its 
cytotoxicity [41]. The potential of glycopolymer containing mannose to interact with human  
DC-SIGN, thereby inhibiting the interactions between DC-SIGN and the HIV envelope glycoprotein 
gp120 was also reported [42]. They prepared a library of glycopolymers and demonstrated that simple 
structures effectively prevent infections. This study has a considerably importance because the  
DC-SIGN is also implicated in the action mechanism of other viruses including Ebola and hepatitis C.  
Following the same strategy, different glycopolymers were synthetized by post-modification to 
inhibit bacterial toxins such as cholera [43–45]. They proved the importance of the glycopolymer 
structure in terms of linker length and branching, carbohydrate density and molecular weight on the 
inhibition of the bacterial toxins. Specifically, longer linkers increase inhibition of the B subunit of 
cholera toxin, which is attributed to the depth of the binding pocket. Moreover, Gibson group also 
demonstrated that branched side chains into the linker in galacto-terminal polymers increase binding 
affinity to their corresponding lectins, relative to simple monosaccharides. 
4. Bioactive Delivery Systems 
Drug delivery systems are one of the main applications of glycopolymers, since, theoretically,  
they do not produce undesirable side effects but can easily reach their targets and increase the 
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solubility of the system. Most of the glycopolymer systems used in drug delivery are nanostructures,  
in particular micellar systems adequate for oral and intravenous delivery route of poorly water-soluble 
drugs (Figure 5). 
 
Figure 5. Scheme of glycopolymer self-assembly along with bioactive drug uptake and 
posterior release of the compound. 
Especially interesting are stimuli responsive systems that allow smart strategies of delivery.  
For instance block glycocopolymer based on poly(azobenzene methacrylate) (PMAzo) and  
poly(3-O-4-vinylbenzoyl-D-glucopyranose) (PBG) was reported (Figure 6). Although this 
glycopolymer has not been used for bioactive delivery, they are able to encapsulate, release, and  
re-encapsulate water-insoluble Nile Red as model compound [46]. PMAzo-b-PBG glycopolymer  
self-assembles into spherical aggregates in water but UV irradiation destabilizes the aggregates as a 
result of the trans–cis isomerization of the MAzo units. The dissociated aggregates reunite to form 
tubular aggregates when the solution is irradiated at 450 nm. 
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Figure 6. Light-induced isomerization of block copolymers poly(azobenzene 
methacrylate)-b-poly(3-O-4-vinylbenzoyl-D-glucopyranose), under alternate ultraviolet 
and visible irradiation for encapsulate-release process.  
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Other glycopolymers have been used to form micelles through their self-aggregation to encapsulate 
gold nanoparticles [47]. In detail, maltoheptaose-b-polystyrene (MH-b-PS) can incorporate PS  
surface-functionalized gold nanoparticles. In this article, the influence of the preparation method of 
micelles on the particle size is described. Nanoprecipitation of the block copolymer solution, where the 
block copolymer molecules exist as well-swollen single chains into a large amount of selective solvent 
for carbohydrate segment, produces micelle nanoparticles of ~30 nm while the reverse procedure 
produces random aggregations and formed large micelles of ~80 nm. 
Suriano et al. [48] have synthetized amphiphilic block glycopolymers containing D-glucose,  
D-galactose and D-mannose by metal-free organocatalyzed ring-opening polymerization. These 
glycopolymers were able to form micelles with particle sizes of 100 nm and low polydispersities, 
which are not toxic to asialoglycoprotein receptors (ASGP-R), positive HepG2 (human liver 
hepatocellular carcinoma) cells or ASGP-R negative HEK293 cells. These authors demonstrated the 
selectivity of galactose-containing micelles that deliver doxorubicin (DOX) more efficiently into 
HepG2 cells than in HEK293 cells. Moreover, the cytotoxicity of DOX against HepG2 cells was 
significantly increased when delivered using the galactose-containing micelles as compared to the free 
DOX formulation and the glucose-containing micelles. It is important to mention that the 
regioisomerism is crucial for binding properties. Glycopolymers carrying different constitutional 
isomers of the pendent sugar species, i.e. the glycosidic linkage of the galactose unit from the 
anomeric position, position 1, and position 6 shows different interaction. The first has strong binding 
to lectins of peanut (Arachis hypogea) agglutinin (PNA) and Erythrina cristagalli agglutinin (ECA), 
while the later does not. More significantly, they show binding behavior similar to the ASGP-R, but 
different internalization pathways in the HepG2 cell after ASGP-R mediated endocytosis [49]. 
Glycopolymers can also be used as nasal drug delivery systems for delivery of proteins and peptides, 
since they can avoid degradation in gastrointestinal tract and metabolism by liver enzymes and are 
non-toxic. However, nasal delivery has to overcome the self-defense mechanisms, such as mucocillary 
clearance, ciliary beat frequency and inflammation, and enzymatic barrier, which affect the permeability 
of drugs through the nasal mucosa. The boronic acid and its derivatives are known to possess the 
ability to reversibly interact with diols, sugars, and glycoproteins, and transport saccharide across lipid 
bilayers. However, the main drawback of these materials is the cytotoxicity. In this sense, glycopolymers 
have been proposed to increase the biocompatibility and hydrophilicity of these compounds. Jin et al. [50] 
described the synthesis of amphiphilic copolymers based on 3-acrylamidophenylboronic acid 
(AAPBA) with maleimide-glucosamine (MAGA) at different ratios (Figure 7).  
 
Figure 7. Different monomers used for copolymerization. 
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They demonstrated the biocompatibility and, therefore, the copolymers are innocuous and do not 
have impact on cell proliferation against NIH 3T3 fibroblast cell line. In addition, insulin was loaded 
into the glycopolymer particles due to both hydrophilic and hydrophobic interactions, with loading 
capacity and encapsulation efficiency of 9–11 and 60%–80% approximately, depending on the 
composition. Afterwards, this group [51] also synthesized a random amphiphilic glycopolymer of 
AAPBA with 2-lactobionamidoethyl methacrylate (LAMA). [51] The self-assembly of this copolymer 
was able to highly load insulin (loading capacity and encapsulation efficiency of 12% and 90%, 
respectively). In addition, they have proved that after nasal administration to diabetic rats, it can 
significantly decrease the glucose levels.  
Stenzel group has synthesized homo and block copolymers with glycomonomer bearing protected 
thiosugar units. These systems can then be converted by post-modification into polymeric gold(I) 
complexes (Figure 8). The formed micelles were tested measuring the proliferation OVCAR-3 human 
ovarian carcinoma cells. [52]. The activity of the block glycopolymer complex is comparable to 
deacetylated auranofin or auranofin, which are potent antitumor drug.  
 
Figure 8. Block copolymer complex structure. 
Likewise, Narain group also synthesized statistical glycopolymers of 3-gluconamidopropyl 
methacrylamide (GAPMA) (Figure 9) with 3-aminopropyl methacrylamide (APMA). These were 
subsequently modified with gold (I) phosphine to form the polymeric complexes [53]. The copolymer 
with lower molecular weight showed higher activity toward different cell lines (Hep G2, HEK 293T, 
MCF-7, and human dermal fibroblasts), especially toward MCF-7 cells. This polymeric complex presented 
higher accumulation and cytotoxicity in cancer cells under hypoxic conditions, which were used to 
mimic the therapy-resistant conditions in cancer diseases, in comparison to the normoxic conditions. 
Posterior, this group also synthesized statistical glycopolymers of 2-gluconamidoethyl methacrylamide 
(GAEMA), 2-lactobionamidoethyl methacrylamide (LAEMA) (see also Figure 9), and glycidyl 
methacrylamide (GMA) with different molecular weights [54]. These glycopolymers are decorated 
with dithiocarbamate to prepare conjugated glyconanoparticles with the anticancer drug, gold (I) 
triphenylphosphine, which were then used for targeted delivery to ASGP-R overexpressing HepG2 cells. 
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Figure 9. Different glycomonomer structures.  
Fleming et al. [55] prepared a carbohydrate-antioxidant hybrid polymer using a different approach 
in order to deliver vitamin E, α-tocopherol, to porcine spermatozoa. The results demonstrated the 
interaction between the polymer and the galactose-binding protein presented on the mammalian 
spermatozoa, followed by the endocytosis and release of antioxidant. Consequently, an increase of 
fertilization rates by a diminishment of the degradation process is produced. 
Series of diblock glycopolycations of 2-deoxy-2-methacrylamido glucopyranose (MAG),  
N-[3-(N,N-dimethylamino) propyl] methacrylamide (DMAPMA), and N-(2-aminoethyl) 
methacrylamide (AEMA) have been developed by aqueous RAFT [56]. These glycopolymers are all 
able to complex plasmid DNA into polyplex structures and to prevent colloidal aggregation of 
polyplexes in physiological salt conditions. Moreover, they are able to transfect in HeLa (human 
cervix adenocarcinoma) cells and HepG2 cells, being much higher in those with AEMA primary 
amine blocks and in HepG2 cells than in HeLa cells. Therefore, the glyco-block benefits the 
hepatocyte transfection and DNA delivery.  
A series of cyclodextrin-based mannose and fucose glycoconjugates, including glycoclusters, star 
glycopolymers and star diblock glycopolymers, have also been synthesized via combination of 
copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC) Huisgen coupling and ATRP. These 
glycoconjugates showed high affinity binding to the human transmembrane lectin DC-SIGN and act as 
inhibitors to prevent the binding of human immunodeficiency virus (HIV) envelope protein gp120 to 
DC-SIGN at nanomolar concentrations as demonstrated before. In addition, the star diblock 
glycopolymers showed high loading capacity of hydrophobic 1,4-dihydroxyanthraquinone and 
Saquinavir mesylate as anticancer and anti-HIV drugs, respectively. [57]  
5. Vaccines 
Glycopolymers can also be good candidates to develop vaccines and to provide active acquired 
immunity against diseases [58,59]. A polymerizable version of the Tn-antigen glycan has been 
prepared and converted into well-defined glycopolymers by RAFT polymerization [60]. These 
glycopolymers were then conjugated to gold nanoparticles with narrow size distribution of diameter 
between 5 and 20 nm. Immunologically, these nanomaterials generated strong and long-lasting 
production of antibodies that are selective to the Tn-antigen glycan and cross-reactive toward mucin 
proteins displaying Tn.  
Very recently, a block glycopolymer has been prepared by cyanoxyl-mediated free radical 
polymerization followed by conjugation with a tumor associated carbohydrate antigens (TACA) Tn 
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antigen and a mouse T helper cells (Th cells) peptide epitope derived from polio virus to afford the 
vaccine construct (Figure 10) [61].  
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Figure 10. Glycopolymer vaccine structure. 
The glycopolymer vaccine stimulated an anti-Tn immune response with significant titers of IgG 
antibodies, which recognized Tn-expressing tumor cells. Although glycopolymeric platforms are still 
discreet, they offer great flexibilities to adjust antibody generator density, valence and the ratio of 
tumor associated carbohydrate antigens (TACA) against Th epitope. In addition, the immunogenicity 
of the glycopolymer backbone is not elevated, which probably will not compete significantly with the 
desired TACA for B cell activation. 
6. Sensors 
Due to the binding capacity of glycopolymers towards protein and bacteria, they have been 
extensively investigated as fundamental part of biosensors systems, mostly of them based on gold 
nanoparticles/surfaces and in their plasmonic properties. As commented above bacterial infections are 
today one of the people major concerns and glycopolymers can help in the solution as bacterial sensor. 
Gold nanoparticles with carbohydrates directly immobilized on their surface by Au-S bond formation 
showed very rapid responses to both lectins and lectin-expressing bacteria. In this sense, Richard et al. [62] 
have described a system capable of discriminating between different strains of Escherichia coli using 
this approach; that is, gold nanoparticles functionalized with poly(ethylene glycol) (PEG) with 
galactose and mannose-ended (Figure 11). The use of the PEG chains increases the saline stability 
retaining their biorecognition properties. The optical properties of nanoparticles change when bind to 
protein FimH positive bacteria, enabling the identification of bacteria strain. 
 
Figure 11. Schematic representation of glycopolymers attached to (A) gold particles and 
(B) flat gold surface, e.g., quartz crystal microbalance. 
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Other statistical glycopolymers having pendant thioglycosides have been synthetized by RAFT and 
then immobilized on gold nanoparticles as well as on quartz crystal microbalance (QCM). They 
showed strong and specific binding with their corresponding lectins, with estimated association 
constant (Ka) values of around 107 M−1 [63]. This value is reached with only 10% carbohydrate units, 
which gives an idea of the strong glycocluster effect (the interaction between lectin and free saccharide 
molecule is around 103 M−1). 
p-Acrylamidophenyl-α-D-mannopyranoside homopolymers and mannose-incorporating nanogel 
particles have been immobilized on nano-imprinted cyclo-olefin polymer films [64]. The strong and 
specific interactions between the mannose-incorporating polymers and Con A lectin were analyzed by 
monitoring the changes in the reflection intensity of the film. The nanogel particles showed a larger 
binding capacity compared with the homopolymers, and are able to detect low protein concentrations 
(with a detection limit of 6.0 ng/mL). Furthermore, the detection limit of the developed biosensor was 
lower than that of surface plasmon resonance sensor (1.43 mg/mL). 
Very recently, amphiphilic block glycopolymers based on 2-O-methacryloyloxyethyl-(β-D-lactose) 
(Lac) and 4-pyridilmethyl methacrylate (PyMA) have been synthesized by RAFT process. Through the 
pyridine groups those can be chemo-adsorbed onto gold surface of QCM [65]. The constant value 
obtained for the specific binding with RCA120 is 6.26 × 106 M−1. This approach was also employed to 
modify gold nanorods. A very small amount of lectin (100 pg/mL = 8.3 × 10−13 M) was detected by the 
aggregation of these glyco-gold nanorods, which gives idea of the potential of these systems [66]. 
Statistical glycopolymers of LAEMA and cationic 2-aminoethyl methacrylamide hydrochloride 
(AEMA) monomers obtained by RAFT polymerization were immobilized on a sensor surface for 
studies of bacterial adhesion by QCM with dissipation [67]. Galactose specific lectin RCA120 was used 
to test the QCM bacterial adhesion. Then, significantly higher amount of Pseudomonas aeruginosa 
PAO1 adhere on the glycopolymer surface with strong contact point stiffness as compared to E. coli 
K-12, since P. aeruginosa has galactose-specific binding while E. coli has mannose-specific one. 
Moreover, RAFT glycopolymers of acrylamide and glycomonomer bearing triazole-linked 
sialyloligosaccharides have been also immobilized on a gold-coated sensor of QCM. These 
glycopolymers strongly bind to both human and avian influenza A viruses [68]. 
Layer-by-layer (LbL) is a widely used technique for thin film preparation. It consists of the alternate 
deposition of interacting species on a substrate with an intervening rinsing step following each 
deposition [69]. Usawa et al. [70] employed LbL adsorption methodology for the assembly of 
glycochips by using polyanionic glycopolymers (Figure 12). They prepared three glycochips carrying 
globobioside (Gb2), β-lactoside (β-Lac), or α-D-mannoside (α-Man) residues for the detection of Shiga 
toxins, Stx1 and Stx2, by surface plasmon resonance (SPR). Stx1 and Stx2 toxins show binding 
specificity for the Gb2 glycochip and a weak affinity for the β-Lac glycochip. Therefore, they give 
different SPR response allowing discriminating between the two toxins. 
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Figure 12. Schematic representation of layer-by-layer preparation of glycochips. 
7. Imaging and Diagnostic  
7.1. Glycopolymers 
The early detection of tumors or other illnesses are attracting ongoing attention. Nowadays,  
the development of systems with high cellular internalization efficiency and specificity, as well as low 
toxicity and good stability is of urgent need. Related to this, the conjugation of glycopolymers with 
contrast agent probes is a very promising alternative to achieve these purposes [71]. Wang et al. [72] 
have terpolymerized glucose- and lactose-containing methacrylate (GEMA and MAMA) monomers 
with radiopaque 2-(2’-iodobenzoyl)-ethyl methacrylate (2-IEMA) in presence of methyl methacrylate 
(MMA) as target imaging carrier materials for controlled drug release. These materials are thermally 
stable and a 0.50 mm thick terpolymer disk exhibits radiopacity similar to a 0.88 mm thick aluminum 
plate. Both glycopolymeric systems are radiopaque but the most of them is the one based on LAMA 
with a molar fraction of 0.5. Computed Tomography (CT) showed that aqueous solution of 
terpolymers with glycopolymer compositions of 0.5, especially lactose derivative, enhances visibility 
in the liver and kidney organs. CT values demonstrated that glycopolymer stays in kidney organs for at 
least one hour without an appreciable loss of contrast.  
Nevertheless, the conjugation with fluorescent probe is probably the most investigated strategy. 
Mannose-derivative of 2-hydroxyethyl methacrylate (MEMA) glycomonomer was copolymerized at 
different molar fractions with HEMA to analyze the ability to interact with Con A [73]. Besides, it was 
copolymerized with fluorescence 7-(N-(4-vinylbenzyl)amino)-4-trifluoromethylcoumarin to visualize 
the cellular internalization via endocytosis without apparent damage to the HeLa cells. The no toxicity 
of the glycopolymer was demonstrated on the basis of the maintenance of NADH dehydrogenase 
activity of cells after incubation for 24 hours. 
Another fluorescence glycopolymer has been synthesized by simultaneous atom transfer  
radical polymerization (ATRP) and click chemistry using as fluorescent initiator  
N,N’-bis{2-[2-[(2-bromo-2-methylpropanoyl)oxy]ethoxy]ethyl}perylene-3,4,9,10-tetracarboxylic acid 
bisimide [74]. The glycopolymers with different length emit strong green fluorescence and exhibit 
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good biocompatibility with 3T3 fibroblasts, macrophages, and KB cells. Therefore, they can also be 
used as cell labeling agents. 
In addition, glycopolymers with near infrared fluorescence have been synthesized employing a 
combination of ring opening polymerization and RAFT polymerization, followed by post-functionalization 
with an aminocyanine molecule [75]. These materials after incubation with HepG2 cells for 72 h 
showed low toxicity even at concentration as high as 0.25 mg mL−1. They undergo enhanced and fast 
endocytosis due to the specific interaction of galactose glycopolymer with HepG2 cells. 
7.2. Hybrid Materials 
The groups of Zhao and Chen have synthesized by RAFT process copolymers of MAG and 
methacrylic acid (MAA). They used these glycopolymers as templates to prepare fluorescent 
glycopolymer-functionalized silver nanoclusters (with particle size of ~5 nm) through microwave 
irradiation [76]. The bioactivity of these systems has been evaluated using GLUT-1 over-expressing 
cancer cells K562, showing great toxicity over them. Furthermore, they have obtained  
porphyrin-glycopolymer conjugates based on this MAG glycomonomer. Glycoparticles (~200 nm) 
showed enhanced binding ability toward Con A, due to the stronger multivalent effect displayed by the 
sufficient numbers of glucose groups on the surface of the nanoparticles. They were also able to 
efficiently bind cancer cells K562 and kill them under light irradiation. Therefore, these systems can 
be used as photosensitizer for cancer imaging and also in photodynamic therapy [77]. 
In addition, star-shaped porphyrin-cored block copolymers based on gluconamidoethyl 
methacrylate (GAMA) have been also synthesized by RAFT using as macroinitiator poly(L-Lactide) 
with anchored porphyrin (SPPLA) [78]. These glycopolymers showed specific recognition with Con 
A. Furthermore, SPPLA-b-PGAMA26 block copolymer exhibited efficient singlet oxygen generation 
and high fluorescence quantum yields. Its cytotoxicity against COS-7 cells was very low and, when 
given a longer irradiation time, more BEL-7402 cancer cells died. Consequently, it can be useful for 
photodynamic therapy.  
Glycopolymers have also been combined with boron-dipyrromethene (BODIPY) for direct  
tumor cell imaging [79]. Statistical glycopolymer showing high water solubility based on  
galactose-derivative of 2-hydroxyethyl methacrylate (GaEMA) glycomonomer and BODIPY 
fluorescent dye monomer was developed. It presented good photo-stability and no cytotoxicity against 
HepG2 and NIH3T3 cells. The viability of cells was higher than the corresponding parent copolymer 
based on 2-hydroxyethyl methacrylate (HEMA) and BODIPY, indicating that galactose units decrease 
the toxicity. Moreover, its fluorescence quantum yield was 1.7 times higher than that of a BODIPY 
monomer because of the incorporation of galactose. Besides, this glycopolymer leads to efficient 
internalization into HepG2 and clear visualizations in cytoplasm, distinguishing between HepG2 and 
NIH3T3 cells. 
Very recently, glycopolymers of 1-(methacrylamido) glucopyranose (1-MAG) fluorescently labeled 
with fluorescein isothiocyanate (FITC) have been synthesized by RAFT process. Additionally, gold 
nanoparticles with poly(N-hydroxyethyl acrylamide) attached onto the surface by thiol group have also 
been prepared [80]. These nanoparticles were subsequently reacted with glucosamine hydrochloride to 
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generate glycosylated nanoparticles. None of these systems are hemolytic and do not induce 
morphological changes in the cells. Therefore, they can be used in diagnostics or therapies. 
One step further described in literature is the preparation of magnetic nanoparticles covered with 
FITC-labeled glycopolymer yielded fluorescent [81,82]. In these publications the visualization of the 
nanoparticles by fluorescence imaging is studied, but the possibility of application in magnetic 
resonance imaging (MRI) is also opened.  
Magnetic nanoparticles represent one of the most important nanomaterials in the diagnosis and 
treatment of cancer. Nanosystems based on iron oxide nanoparticles are currently being applied as 
contrast agent in MRI [83]. The use of nanoparticles in cancer therapy is highly convenient because of 
so-called enhanced permeability and retention effect. The tumor vessels are altered in comparison with 
those in sane cells and the nanoparticles from the blood can be internalized better into tumor tissues, 
thus selectively accumulated. When this phenomenon is combined with other targeting strategies by 
incorporation of specific moieties the resulting nanosystems can exhibit enhanced diagnostic capacity 
for a more specific treatment and at the same time less aggressive to the human body as the required 
dose can be considerably reduced. The attachment of glycopolymers onto the iron oxide nanoparticles 
allows this selective localization of the nanoparticles concomitantly with an increase in the colloidal 
stability of the nanoparticles [84]. Several studies are found in literature concerning the functionalization 
of magnetic nanoparticles with glycopolymers for MRI applications. A series of diblock glycopolymers 
based on PEG and different carbohydrates, α-D-mannose, α-D-glucose and β-D-glucose, have been 
attached to iron oxide nanoparticle surfaces and the influence of the binding ability of the resulting 
nanosystems on the MRI signal was evaluated [85]. Remarkably, the α-D-mannose functionalized 
magnetic nanoparticles showed an improved cell uptake in a lung cancer cell line (A549) and also 
exhibited high r2 transverse relaxivity when measured in a 9.4 T MRI. More important, the binding of 
the nanoparticles to the lectin Con A produces a significant change in T2 relaxation, which is 
proportional to the lectin concentration, thus enhancing the diagnosis future perspectives.  
In another study, iron oxide nanoparticles have been functionalized with poly  
(vinylbenzyl-O-β-D-galactopyranosyl-D-gluconamide) that contain galactose units, thus able to be 
recognized by asialoglycoprotein receptors on hepatocytes [86]. In vivo experiments in rats show that 
after injection the signal intensity of liver largely dropped on T2-weighted MR image revealing that the 
nanoparticles are mainly accumulated in liver. Therefore, these nanoparticles can present a potential as 
contrast liver-targeting MRI contrast agent. 
8. Future Developments and Conclusions 
Up to here, promising applications of glycopolymers are presented; however, this type of materials 
can also be used in very different matters that could lead to a number of future applications. This is the 
case of glycopolymers used to optically observe the conformations of structurally well-defined 
polymers anchored to fluid lipid membranes [87]. Remarkable phase control on the crystallization of 
calcium carbonate by the stereochemistry of glycopolymers has been achieved. The selection of phase 
is based on the chelating character of the hydroxyl groups of the pyranoses (glucose or galactose) and 
their individual orientation, which allow to the control biomineralization processes [88]. Recently, 
ionotropic gelation has been reported on glycopolymers synthesized by copolymerization of  
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2-hydroxyethyl methacrylamide and acrylamide- and methacrylamide-type macromonomers obtained 
by modification of alginate-derived oligosaccharides [89]. These hydrogels formed under mild 
conditions have potential applications in cell encapsulation and in vitro 3D cell culture. Moreover, 
glycopolymers are highly hemocompatible and do not induce clot formation, red blood cell 
aggregation, and immune response, thereby these macromolecular structures could be very useful in 
many different in vivo applications [90]. In summary, these materials are promising systems for 
diverse biological, biomedical and other related activities. In this sense, the cost-effective and 
straightforward synthesis of adequate glycomonomers and glycopolymers is essential; therefore, 
chemistry as well as its combination with different areas, such as biology and biomedicine to 
understand their behavior, mathematics, and physics to model, such as behavior, analytical, and 
nanotechnology to implement their properties, and others, will allow enlarging the glycopolymeric 
material applications.  
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